We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

LISN:SIXChocoladefabriken Lindt & Spruengli AG Analysis

Data as of 2026-06-19 - not real-time

CHF 93,800.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Lindt & Sprüngli is trading at CHF 93,800, which sits below its 20‑day (CHF 94,840), 50‑day (CHF 101,948) and 200‑day (CHF 115,274) simple moving averages, signaling a bearish price trend. RSI is at 30.35, flirting with oversold territory, while the MACD histogram shows a positive 330 points and the signal is flagged as bullish, suggesting a possible short‑term momentum reversal. The stock is hugging its immediate support level of CHF 92,400 with resistance near CHF 100,900, and volume is on an upward trend, adding weight to a tentative bounce. Fundamentally, the company delivers solid margins (gross 62.8%, operating 20.1%) and a 7.5% revenue growth rate, yet valuation multiples are stretched – a PE of 29.9 and PB of 4.35 far exceed typical consumer‑defensive norms, and the discounted‑cash‑flow fair value of CHF 3,149 is dramatically lower than the market price. The balance sheet shows moderate leverage (debt‑to‑equity 35.6%) with ample cash, but the absence of a dividend and an “Extreme Greed” market sentiment (Fear & Greed Index 91.46) heighten the overvaluation concern.
Overall, the stock sits in a low‑beta (‑0.06) environment with 30‑day volatility around 17%, indicating limited market correlation but notable price swings. While the defensive sector and strong brand cushion downside risk, the combination of high multiples, lack of dividend income, and a sizable recent drawdown (~30%) suggest caution for investors seeking value, even as short‑term technical cues hint at a modest rebound opportunity.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • RSI near oversold levels
  • Bullish MACD histogram
  • Price approaching key support

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Elevated valuation multiples
  • Strong operating margins
  • Moderate leverage with solid cash position

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Defensive consumer sector positioning
  • Sustainable revenue growth and brand strength
  • Lack of dividend and high price-to-earnings ratio

Key Metrics & Analysis

Financial Health

Revenue Growth7.50%
Profit Margin12.22%
P/E Ratio29.9
ROE14.84%
ROA6.71%
Debt/Equity35.61
P/B Ratio4.4
Op. Cash FlowCHF520.4M
Free Cash FlowCHF249.0M

Technical Analysis

TrendBearish
RSI30.4
SupportCHF 92,400.00
ResistanceCHF 100,900.00
MA 20CHF 94,840.00
MA 50CHF 101,948.00
MA 200CHF 115,274.00
MACDBullish
VolumeIncreasing
Fear & Greed Index91.46

Valuation

Fair ValueCHF 3,148.63
GradeOvervalued
TypeGrowth

Risk Assessment

Beta-0.06
Volatility17.06%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.